FindTrial
Sign In

Application of molecular pathological diagnosis technique from COVID-19 lung tissue samples

Application of molecular pathological diagnosis technique from COVID-19 lung tissue samples

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048050
Enrollment
Unknown
Registered
2021-06-28
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:Nil

Sponsors

The First Affiliated Hospital of Army Medical University, PLA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Clinically diagnosed as COVID-19 died patients and control lung samples judged under microscope.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Gene;Cell;Signal pathway;—

Countries

China

Contacts

Public ContactYao Xiaohong

The First Affiliated Hospital of Army Medical University, PLA

yxh15@163.com+86 15923566825

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026